Please provide your email address to receive an email when new articles are posted on . Clinical presentation of a 42-year-old man with acute onset of ocular discomfort and mild conjunctival infection ...
We investigated the efficacy of lacrimal punctal occlusion surgery with a cautery device in patients with chronic GVHD (cGVHD)-related dry eye, with recanalization of puncta and recurrent punctal plug ...
Please provide your email address to receive an email when new articles are posted on . There is general agreement in ophthalmology that punctal plugs are indicated when first line treatment with ...
BEDFORD, Mass., Aug. 20, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical ...
VANCOUVER, July 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced encouraging interim data from an ongoing Phase ...
VANCOUVER, British Columbia, Aug. 29, 2011 (GLOBE NEWSWIRE) -- QLT Inc. /quotes/zigman/13615/quotes/nls/qlti QLTI +1.81% /quotes/zigman/13629 CA:QLT +1.99% today ...
QLT Inc. announced results of its phase II clinical study on the efficacy and safety of the Latanoprost Punctal Plug Delivery System (LPPDS) in subjects with Ocular Hypertension (OH) and Open-Angle ...
Two-month sustained release drug may improve therapy over topical drop administration. BEDFORD, Mass., Aug. 21, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback